Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical Isolates
Crossref DOI link: https://doi.org/10.1007/s40121-016-0133-y
Published Online: 2016-10-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smart, Jennifer I.
Corey, Gordon Ralph
Stryjewski, Martin E.
Wang, Whedy
Barriere, Steven L.
Funding for this research was provided by:
Theravance Biopharma US, Inc